Skip to main content
    S

    Structure Therapeutics Inc. American Depositary Shares (GPCR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $21.88
    -0.43 (-1.93%)

    Market Cap: $1.56B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    47%(7/15)
    Avg Surprise
    -12.79%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.24
    Range$-0.57 - $2.02
    10 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.19-28.9%
    60d ago$-0.19-28.9%
    30d ago$-0.23-3.4%
    7d ago$-0.240.0%
    Current$-0.24
    Revenue Consensus
    $50M
    Range$0 - $500M
    10 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.68
    Range$-1.11 - $1.87
    11 analysts
    Revenue Consensus
    $-19444440
    Range$-61111110 - $439M
    12 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.68---
    Sep 26EST
    		-$-0.24---
    Jun 26
    Reported Aug 6
    		$-0.49$-0.39-25.64%Miss-36.1%
    Mar 26
    Reported May 7
    		$-0.35$-0.33-6.06%Miss-29.6%
    Dec 25
    Reported Feb 26
    		$-0.49$-0.35-40.00%Miss-133.3%
    Sep 25
    Reported Nov 6
    		$-0.37$-0.37+0.00%Beat-85.0%
    Jun 25
    Reported Aug 6
    		$-0.36$-0.28-28.57%Miss-100.0%
    Mar 25
    Reported May 8
    		$-0.27$-0.23-17.39%Miss-42.1%
    Dec 24
    Reported Feb 27
    		$-0.21$-0.28+25.00%Beat+60.5%
    Sep 24
    Reported Nov 13
    		$-0.20$-0.19-5.26%Miss+4.8%
    Jun 24
    Reported Aug 8
    		$-0.18$-0.23+21.74%Beat+10.0%
    Mar 24
    Reported May 9
    		$-0.19$-0.22+13.64%Beat+24.0%
    Dec 23
    Reported Mar 8
    		$-0.53$-0.21-153.14%Miss+53.4%
    Sep 23
    Reported Nov 14
    		$-0.21$-0.22+4.55%Beat-76.9%
    Jun 23
    Reported Aug 10
    		$-0.20$-0.27+25.93%Beat-57.4%
    Mar 23
    Reported May 11
    		$-0.25$-0.37+32.43%Beat-109.7%
    Dec 22
    Reported Mar 31
    		$-1.14$-0.82-39.02%Miss-1139900.0%
    Sep 22
    Reported Sep 30
    		$-0.12N/AN/ABeat-
    Jun 22
    Reported Jun 30
    		$-0.13N/AN/ABeat-
    Mar 22
    Reported Mar 31
    		$-0.12N/AN/ABeat-
    Dec 21
    Reported Dec 31
    		$-0.00N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-12.87EV/EBITDAN/A
    Price/FCF-7.08xFCF Yield-14.13%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-20.20%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio20.75xQuick Ratio20.75x
    Trading Statistics
    Beta-1.37Avg Volume1.49M
    52-Week High$94.9052-Week Low$21.55

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$25.77
    SMA 20$30.42
    SMA 50$40.96
    SMA 200$51.92
    EMA 10$25.96
    EMA 20$29.90
    EMA 50$37.14
    EMA 200$43.90

    MACD

    Line: -5.07Signal: -4.64Hist: -0.43

    ADX

    ADX: 56.7+DI: 6.2-DI: 48.8

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$27.62

    Bollinger Bands

    Upper Band$40.82
    Lower Band$20.03
    %B Position6835%(Upper)
    Band Width0.09

    RSI (14-Day)

    Oversold
    11.1

    Momentum Oscillators

    Stoch %K1.2
    Stoch %D1.9
    Williams %R-97.9
    ROC (10d)-30.0%
    Momentum-9.39
    CCI (20d)-124.4
    MFI (14d)9.2

    Volatility Measures

    ATR (14d)$1.88(8.6%)
    StdDev (20d)5.20
    Hist Vol49.1%(High)

    Volume Flow

    VWAP$22.11
    OBV1.0M
    AD Line-39.1M
    CMF (20d)-0.361

    Volume Metrics

    Avg Vol (20d)1.5M
    Vol Ratio1.2x
    VWMA (20d)$30.29

    Pivot Points

    R3$25.46
    R2$24.74
    R1$23.53
    Pivot Point$22.81
    S1$21.60
    S2$20.88
    S3$19.67

    Advanced Oscillators

    TSI-68.04
    Ultimate Osc23.8
    KST-377.16

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$1.78M$0$0$0$1.33M$0
    Cost of RevenueN/A$1.22MN/AN/A$853,991$686,976N/A$267,175$231,736$658,927$280,918$351,022
    Gross ProfitN/A$-1,218,622N/AN/A$-853,991$-686,976$890,663$-267,175$-231,736$-658,927$1.05M$-351,022
    Operating Expenses$118.63M$88.43M$-23,989,000$73.79M$70.45M$56.31M$47.06M$45.84M$33.32M$32.02M$30.99M$26.14M
    R&D$100.06M$66.71M$68.69M$58.99M$54.71M$42.87M$33.49M$32.60M$22.05M$20.68M$20.04M$17.52M
    SG&A$18.57M$22.87M$17.57M$14.80M$15.74M$13.44M$13.57M$13.24M$11.27M$11.34M$10.95M$8.63M
    Operating Income$-118,630,000$-89,645,505$23.99M$-73,787,000$-70,451,000$-56,311,000$-47,061,000$-45,836,000$-33,316,000$-32,015,000$-30,994,000$-26,145,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$6.01M$9.58M$2.83M
    Income Before Tax$-105,925,000$-76,003,951$33.17M$-65,604,000$-61,522,000$-46,735,000$-36,343,000$-33,885,000$-25,981,000$-26,007,000$-24,815,000$-23,457,000
    Income Tax Expense$234,000$190,566$170,000$108,000$139,000$98,000$136,000$92,000$53,000$29,000$-312,000$405,000
    Net Income$-106,159,000$-76,194,517$33.00M$-65,712,000$-61,661,000$-46,833,000$-36,479,000$-33,977,000$-26,034,000$-26,036,000$-24,503,000$-23,862,000
    EBITDA$-105,374,000$-75,427,951$33.59M$-65,248,000$-61,231,000$-46,461,000$-36,070,000$-33,620,000$-25,749,000$-25,785,000$-24,743,000$-23,378,000
    EBIT$-105,925,000$-76,003,951$33.17M$-65,604,000$-61,522,000$-46,735,000$-36,343,000$-33,885,000$-25,981,000$-26,007,000$-24,815,000$-23,457,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about GPCR

    News

    Trading Systems Reacting to (GPCR) Volatility

    This article from Stock Traders Daily discusses the volatility in Structure Therapeutics Inc. (NASDAQ: GPCR), identifying weak sentiment across all time horizons...

    Stock Traders Daily•10/12/26•Bearish

    Structure Therapeutics stock hits 52-week low at 25.56 USD By Investing.com

    Structure Therapeutics Inc ADR stock has dropped to a 52-week low of $25.56, marking a 62% year-to-date decline. Despite the downturn, InvestingPro analysis suggests the stock is undervalued and oversold...

    Investing.com Nigeria•10/8/26•Somewhat-Bullish

    Structure Therapeutics stock hits 52-week low at 25.56 USD By Investing.com

    Structure Therapeutics Inc ADR (GPCR) has hit a 52-week low of $25.56, reflecting a 62% year-to-date decline. Despite this, InvestingPro suggests the stock is undervalued...

    Investing.com India•10/8/26•Somewhat-Bullish

    We Think Structure Therapeutics (NASDAQ:GPCR) Can Afford To Drive Business Growth

    Structure Therapeutics (NASDAQ:GPCR) has a significant cash reserve of US$474m, which is sufficient to fund its operating expenses and capital expenditures for at least two years. The company recently reported a net loss...

    Moomoo•9/30/26•Bullish

    Structure Therapeutics Inc. (GPCR) Stock Price, News, Quote & History

    Structure Therapeutics Inc. (GPCR) is a clinical-stage biopharmaceutical company focused on developing novel oral small molecule therapeutics for chronic diseases...

    Yahoo! Finance Canada•9/23/26•Neutral

    GPCR Valuation and Fair Value

    P/E
    -12.9x
    P/FCF
    -7.1x
    P/B
    1.2x
    See GNG's fair value

    GPCR Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -20.2%
    FCF yield
    -14.1%

    GPCR Competitors

    CompanyTicker
    RAPT Therapeutics IncRAPT
    Phibro Animal Health CorporationPAHC
    Compass Pathways PlcCMPS
    Eton Pharmaceuticals IncETON
    Ocular Therapeutix IncOCUL
    Stoke Therapeutics IncSTOK
    Kestra Medical Technologies, Ltd. Common StockKMTS
    Innoviva IncINVA

    Sector: Healthcare

    GPCR Analyst Ratings

    Consensus
    Buy
    Analysts
    16
    Strong Buy
    4
    Buy
    11
    Hold
    1
    Sell
    0
    Strong Sell
    0

    GPCR Bull Case vs Bear Case

    Bull case

    • 93.8% of GPCR's analyst ratings are Buy or Strong Buy.

    Bear case

    • GPCR beat EPS estimates in 12.5% of its last 8 reported quarters.

    GPCR Earnings: Beat Rate and Next Report

    Beat rate
    1 of 8 quarters (12.5%)
    Average surprise
    -12.2%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.24
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About GPCR

    Does GPCR pay dividends?

    Structure Therapeutics Inc. American Depositary Shares (GPCR) does not currently pay a regular dividend.

    What is GPCR's market cap?

    Structure Therapeutics Inc. American Depositary Shares (GPCR) has a market capitalization of $1.56B with a current stock price of $21.88.

    Related stocks

    Sector: Healthcare

    All stocks starting with G

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In